Prosecution Insights
Last updated: November 08, 2026
Application No. 19/009,753

METHODS AND DEVICES FOR RENAL ACCESS AND PRESSURE REDUCTION

Non-Final OA §102§103
Filed
Jan 03, 2025
Priority
Jan 04, 2024 — provisional 63/617,490 +1 more
Examiner
GHERBI, SUZETTE JAIME J
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Exploramed V LLC
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
1199 granted / 1408 resolved
+15.2% vs TC avg
Moderate +9% lift
Without
With
+8.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
27 currently pending
Career history
1437
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
39.6%
-0.4% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
11.2%
-28.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1408 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. MPEP 2114 States: II. MANNER OF OPERATING THE DEVICE DOES NOT DIFFERENTIATE APPARATUS CLAIM FROM THE PRIOR ART "[A]pparatus claims cover what a device is, not what a device does." Hewlett-Packard Co. v. Bausch & Lomb Inc., 909 F.2d 1464, 1469, 15 USPQ2d 1525, 1528 (Fed. Cir. 1990) (emphasis in original). A claim containing a "recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus" if the prior art apparatus teaches all the structural limitations of the claim.” Ex parte Masham, 2 USPQ2d 1647 (Bd. Pat. App. & Inter. 1987) (The preamble of claim 1 recited that the apparatus was "for mixing flowing developer material" and the body of the claim recited "means for mixing ..., said mixing means being stationary and completely submerged in the developer material." The claim was rejected over a reference which taught all the structural limitations of the claim for the intended use of mixing flowing developer. However, the mixer was only partially submerged in the developer material. The Board held that the amount of submersion is immaterial to the structure of the mixer and thus the claim was properly rejected.) Claim(s) 1-9, 13, 17, 19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wynberg 2013/0274783. PNG media_image1.png 294 492 media_image1.png Greyscale Regarding claims 1, Wynberg discloses the invention as claimed comprising: a system ([0145]; 0193]) for renal access and pressure reduction, comprising: an apparatus that provides access to a kidney; and an interventional apparatus that engages a renal tissue ([0246]), the interventional apparatus being sized and shaped to be advanced to the kidney. Regarding claims 2 and 9, Wynberg discloses further comprising a needle (see [0015] which states using an 18-gauge needle passed over a puncture wire configured to pierce) having a distal end configured to pierce a renal capsule. Regarding claim 3, Wynberg discloses a catheter or sheath sized and shaped to provide a path for the interventional apparatus to engage the renal tissue (see [0016]). Regarding claims 4-7 “comprising a guidewire sized and shaped to be advanced to engage the renal tissue” see [0016]). “wherein the interventional apparatus is sized and shaped to be advanced within vasculature to the kidney” is functional language. See MPEP 2114. Wynberg is capable of performing the functions as claimed. Regarding claim 8 see “C” in fig. 27. Regarding claim 13 see [0108] for a balloon. Regarding claim 17 see ([0015]) for a steerable device. Regarding claim 19 “configured to treat multiple areas of a kidney is functional language. See MPEP 2114 supra. Claim(s) 1-7, 9, 13-14, 17-19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kapur et al. 2022/0218393. Kapur et al. discloses a system (300) for renal access and pressure reduction, comprising: PNG media_image2.png 386 483 media_image2.png Greyscale an apparatus that provides access to a kidney; and an interventional apparatus that engages a renal tissue, the interventional apparatus being sized and shaped to be advanced to the kidney (see [0043]). Regarding claim 2 discloses further comprising a needle (see [0043] needle tip 310) having a distal end configured to pierce a renal capsule. Regarding claim 3, Kapur et al. discloses a catheter (308) or sheath sized and shaped to provide a path for the interventional apparatus to engage the renal tissue. Regarding claims 4-7 “comprising a guidewire (302) sized and shaped to be advanced to engage the renal tissue”. The phrase “wherein the interventional apparatus is sized and shaped to be advanced within vasculature to the kidney” is functional language. See MPEP 2114. Kapur et al. is capable of performing the functions as claimed. Regarding claim 9 and 18 Kapur et al. discloses the use of electrocautery [0015] which is able to perform the functions as claimed via an energy device. Regarding claim 13 Kapur et al. discloses the use of a balloon [00015]. See MPEP 2114 supra. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 14 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over Kapur et al. 2022/0218393. Kapur et al. has been disclosed supra however does not utilize the word “stent”. Kapur et al. teaches a spacer device (see [0045] and (320) which is designed to maintain the dilated puncture created in the fibrous capsule of the renal capsule, and to permit fluid communication between the subcapsular space of the renal capsule and the space outside the fibrous capsule. Kapur further states that the spacer device 320 is transitionable from a collapsed delivery state, e.g., within an introductory sheath, where it may be advanced over guidewire 302 via a delivery catheter, to an expanded deployed state. It is obvious to one having ordinary skill in the art that the space of Kapur performs as a stent. Allowable Subject Matter Claims 10-12 and 20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art has been disclosed above however does not recite in combination with the limitations of claim 1 a grommet placed within the hole of a renal capsule; a grommet with spikes or barbs; or a grommet shaped to tent a renal capsule; or a jacket for the kidney. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Suzette Gherbi whose telephone number is (571)272- 4751. The examiner can normally be reached on Monday-Friday 7:00am-3:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http:/Avww.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Melanie Tyson can be reached on 571-272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https:/Awww.uspto.gov/patents/apply/patent- center for more information about Patent Center and https:/Awww.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197. /SUZETTE J GHERBI/Primary Examiner, Art Unit 3774 October 28, 2026
Read full office action

Prosecution Timeline

Jan 03, 2025
Application Filed
Oct 30, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773312
PROSTHETIC HEART VALVE LEAFLET ASSEMBLIES AND METHODS
3y 7m to grant Granted Oct 27, 2026
Patent 12773318
NATIVE VALVE REPAIR DEVICES AND PROCEDURES
2y 8m to grant Granted Oct 27, 2026
Patent 12765995
DEVICES AND SYSTEMS FOR DOCKING A HEART VALVE
4y 1m to grant Granted Oct 20, 2026
Patent 12765987
Implantable Artificial Bronchus
3y 6m to grant Granted Oct 20, 2026
Patent 12758377
FENESTRATION DEVICES, SYSTEMS, AND METHODS FOR AORTIC ARCH REPAIR
3y 4m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
94%
With Interview (+8.7%)
2y 5m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1408 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month